Sign in

CIK 0001815442

  • Large accelerated filer

Kymera Therapeutics, Inc.

Sign in to watch
Ticker
KYMR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812992166
Phone
+1 857-285-5314
Business address
500 NORTH BEACON STREET, 4TH FLOOR, WATERTOWN, MA, 02472
Former names
Kymera Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,158,214
in 2 filings, $3.4M under 10b5-1 plans

Net −$4,158,214. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 68 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-11-02 BVF PARTNERS L P/IL Director Purchase +26,772 $11.64 $312K 284,526
2023-08-08 Mainolfi Nello Chief Executive Officer Exercise or conversion +12,000 $2.08 $25K 586,570
2023-08-08 Mainolfi Nello Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) −12,000 2,368
2023-06-15 BVF PARTNERS L P/IL Director Grant or award · Stock Option (Right to Buy) +12,000 12,000
2023-06-15 Sandor Victor Director Grant or award · Stock Option (Right to Buy) +12,000 12,000
2023-06-15 Ridloff Elena Director Grant or award · Stock Option (Right to Buy) +12,000 12,000
2023-06-15 Morgan Leigh Director Grant or award · Stock Option (Right to Buy) +12,000 12,000
2023-06-15 Booth Bruce Director Grant or award · Stock Option (Right to Buy) +12,000 12,000
2023-06-15 MARAGANORE JOHN Director Grant or award · Stock Option (Right to Buy) +12,000 12,000
2023-06-15 Albers Jeffrey W. Director Grant or award · Stock Option (Right to Buy) +12,000 12,000
2023-06-15 Horobin Joanna Director Grant or award · Stock Option (Right to Buy) +12,000 12,000
2023-06-15 Esposito Pamela Director Grant or award · Stock Option (Right to Buy) +12,000 12,000
2023-06-15 Hrustanovic Gorjan Director Grant or award · Stock Option (Right to Buy) +12,000 12,000
2023-06-02 Jacobs Bruce N. Chief Financial Officer Exercise or conversion +10,000 $2.08 $21K 115,035
2023-06-02 Jacobs Bruce N. Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) +10,000 129,899
2023-05-22 Chadwick Jeremy G Chief Operating Officer Grant or award +33,333 33,333
2023-05-22 Chadwick Jeremy G Chief Operating Officer Grant or award · Stock Option (Right to Buy) +200,000 200,000
2023-03-02 Caughey Elaine Chief Business Officer Sale −550 $30.88 $17K 19,150
2023-03-02 Caughey Elaine Chief Business Officer Sale −164 $31.40 $5K 18,986
2023-03-02 Gollob Jared Chief Medical Officer Sale −1,001 $30.88 $31K 75,006

Page 32 of 41 · 810 trades